Cladribine tablets after treatment with natalizumab (CLADRINA) – rationale and design von Sguigna, Peter V., Hussain, Rehana Z., Okai, Annette, Blackburn, Kyle M., Tardo, Lauren, Madinawala, Mariam, Korich, Julie, Lebson, Lori A., Kaplan, Jeffrey, Salter, Amber, Manouchehri, Navid, Stuve, Olaf

Volltext

Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives von Freedman, Mark S., Coyle, Patricia K., Hellwig, Kerstin, Singer, Barry, Wynn, Daniel, Weinstock-Guttman, Bianca, Markovic-Plese, Silva, Galazka, Andrew, Dangond, Fernando, Korich, Julie, Reder, Anthony T.

Volltext